Senestech (NASDAQ:SNES) versus SNDL (NASDAQ:SNDL) Financial Analysis

Senestech (NASDAQ:SNES) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk.

Earnings & Valuation

This table compares Senestech and SNDL”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senestech	$2.22 million	3.70	-$6.38 million	($2.78)	-0.56
SNDL	$677.32 million	0.57	-$11.29 million	($0.04)	-37.75

Senestech has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Senestech, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

5.2% of Senestech shares are owned by institutional investors. 5.3% of Senestech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

Senestech has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500. Comparatively, SNDL has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Senestech and SNDL, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senestech	1	1	0	1	2.33
SNDL	1	0	1	0	2.00

SNDL has a consensus price target of $5.00, suggesting a potential upside of 231.13%. Given SNDL’s higher possible upside, analysts clearly believe SNDL is more favorable than Senestech.

Profitability

This table compares Senestech and SNDL’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Senestech	-287.39%	-78.74%	-58.47%
SNDL	-1.64%	-1.42%	-1.18%

Summary

SNDL beats Senestech on 8 of the 15 factors compared between the two stocks.

About Senestech

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

About SNDL

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.